Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H27NO3 |
Molecular Weight | 305.4119 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
InChI
InChIKey=YKPUWZUDDOIDPM-SOFGYWHQSA-N
InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+
Molecular Formula | C18H27NO3 |
Molecular Weight | 305.4119 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:08 UTC 2023
by
admin
on
Fri Dec 15 15:11:08 UTC 2023
|
Record UNII |
S07O44R1ZM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
70701
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
269508
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
NCI_THESAURUS |
C68530
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
165502
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
WHO-VATC |
QM02AB01
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
QUTENZA (AUTHORIZED: NEURALGIA)
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
158202
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
WHO-ATC |
N01BX04
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
WHO-ATC |
M02AB01
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
222506
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
DSLD |
3807 (Number of products:4)
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
NCI_THESAURUS |
C2198
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
EU-Orphan Drug |
Capsaicin
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
WHO-VATC |
QN01BX04
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
205705
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2486
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
1091108
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
954
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
3064
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
1992
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB13229MIG
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
3374
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
S07O44R1ZM
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
206-969-8
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
100000076831
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
CAPSAICIN
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
404-86-4
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
m3040
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | Merck Index | ||
|
D002211
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
10145
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
1548943
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
S07O44R1ZM
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
56353
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
DTXSID9020241
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
DB06774
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
CHEMBL294199
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY | |||
|
C339
Created by
admin on Fri Dec 15 15:11:08 UTC 2023 , Edited by admin on Fri Dec 15 15:11:08 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48.6% of Capsaicinoid components.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48.6% of Capsaicinoid components.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48.6% of Capsaicinoid components.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48.6% of Capsaicinoid components.
|
||
|
DERIVATIVE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
EXCRETED UNCHANGED |
There is no human excretion information available for capsaicin
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
WEAK
|
||
|
TARGET -> AGONIST | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48.6% of Capsaicinoid components.
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
WEAK
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
WEAK
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
PRODRUG -> METABOLITE ACTIVE |
HYDROLYSIS INDEPENDENT OF ENZYME
|
||
|
METABOLITE -> PARENT |
In incubation medium and skin vanillic acid ranged from 0.11 to 7.97% of the radioactivity in each sample at all concentrations.
SKIN
|
||
|
METABOLITE -> PARENT |
MINOR
PLASMA
|
||
|
METABOLITE -> PARENT |
In incubation medium and skin vanillylamine ranged from 4.37 to 19.8% of the radioactivity in each sample at all concentrations.
SKIN
|
||
|
METABOLITE -> PARENT |
In human microsomal fraction, 16,17-dehydro-capsaicin was the minor metabolite, but in human S-9 fraction, 16,17-dehydro-capsaicin was the major metabolite.
PLASMA
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |